Sociodemographic and clinical features of the studied sample
| Ages, years, mean±SD | 38.6±12.1 | |
| Sex, male, n (%) | 388 (51.9) | |
| Nationality, n (%) | Qatari | 78 (10.5) |
| Non-Qatari Arab | 88 (11.9) | |
| Indian subcontinent | 260 (35.0) | |
| Southeast Asia | 144 (19.4) | |
| European | 42 (5.7) | |
| North American | 22 (3.0) | |
| Other | 108 (14.5) | |
| Occupation, n (%) | White collar | 456 (61.0) |
| Labourer | 188 (25.2) | |
| Unemployed | 103 (13.8) | |
| COVID-19 PCR test result, n (%) | Negative | 269 (40.1) |
| Positive | 394 (58.8) | |
| Inconclusive | 7 (1.0) | |
| Duration of quarantine, days, mean±SD | 7.0±4.9 | |
| History of depression, n (%) | 21 (2.8) | |
| History of anxiety, n (%) | 43 (5.7) | |
| History of psychosis, n (%) | 1 (0.1) | |
| History of psychotropic medication intake, n (%) | 26 (3.5) | |
| History of admission to psychiatry, n (%) | 17 (2.3) | |
| History of psychotherapy/counselling, n (%) | 13 (1.7) | |
| GAD-7 score, mean±SD | 3.7±4.5 | |
| PHQ-9 score, mean±SD | 4.6±5.0 | |
| Anxiety, n (%) | None | 549 (74.1) |
| Mild | 123 (16.6) | |
| Moderate | 50 (6.7) | |
| Severe | 19 (2.6) | |
| Depression, n (%) | None | 460 (62.6) |
| Mild | 153 (20.8) | |
| Moderate | 75 (10.2) | |
| Moderately severe | 38 (5.2) | |
| Severe | 9 (1.2) | |
.GAD-7, seven-item Generalised Anxiety Disorder scale; PHQ-9, Patient Health Questionnaire nine-item depression scale.